MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$322,933K Accounts receivable, net$224,464K Inventories, net$27,938K Prepaid and othercurrent assets$13,651K Total current assets$588,986K Intangible asset, net$40,519K Non-current inventory andother assets$26,838K Right-of-use asset$20,858K Goodwill$12,042K Equipment, net$562K Total assets$689,805K Total liabilities andstockholders equity$689,805K Total liabilities$601,510K Total stockholdersequity$88,295K Accumulated deficit-$1,305,961K Total currentliabilities$378,836K Loan payable,long-term$117,746K Contingent consideration,non-current$77,540K Operating leaseliability, long-term$23,182K Finance leaseliability, long-term$4,206K Additional paid-in capital$1,394,251K Common stock, 0.0001par value per share...$5K Accrued expenses andother current...$232,853K Short-term borrowings$70,000K Accounts payable$65,537K Contingent consideration,current$10,012K Operating leaseliability, current portion$434K
Balance Sheet
source: myfinsight.com

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM)